CBER

Dendreon draws CBER letter for Provenge professional marketing

August 10, 2010

The Center for Biologics Evaluation and Research hit Dendreon with an untitled letter for false and misleading professional marketing materials for its prostate cancer treatment Provenge.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!